You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis

Citation Tools

Article menu
Download PDFPDF
ePoster
EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bartoletti M, Pelizzari G, Bortot L, et al
EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis
International Journal of Gynecologic Cancer 2019;29:A437-A438.